WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/005534    International Application No.:    PCT/US2006/025402
Publication Date: 11.01.2007 International Filing Date: 28.06.2006
A61K 31/404 (2006.01), A61K 31/435 (2006.01), C07D 221/02 (2006.01)
Applicants: SMITHKLINE BEECHAM CORPORATION [US/US]; One Franklin Plaza, P.o. Box 7929, Philadelphia, PA 19101 (US) (For All Designated States Except US).
DENG, Jianghe [CN/US]; (US) (For US Only).
KERNS, Jeffrey, K. [US/US]; (US) (For US Only).
JIN, Qi [CN/US]; (US) (For US Only).
LIN, Guoliang [CN/US]; (US) (For US Only).
LIN, Xichen [CN/US]; (US) (For US Only).
LINDENMUTH, Michael [US/US]; (US) (For US Only).
NEIPP, Christopher, E. [US/US]; (US) (For US Only).
NIE, Hong [US/US]; (US) (For US Only).
THOMAS, Sonia, M. [US/US]; (US) (For US Only).
WIDDOWSON, Katherine, L. [CA/US]; (US) (For US Only)
Inventors: DENG, Jianghe; (US).
KERNS, Jeffrey, K.; (US).
JIN, Qi; (US).
LIN, Guoliang; (US).
LIN, Xichen; (US).
LINDENMUTH, Michael; (US).
NEIPP, Christopher, E.; (US).
NIE, Hong; (US).
THOMAS, Sonia, M.; (US).
WIDDOWSON, Katherine, L.; (US)
Agent: MADDEN, Laura, K.; GLAXOSMITHKLINE, CORPORATE INTELLECTUAL PROPERTY, UW2220, 709 Swedeland Road, P.o. Box 1539, King Of Prussia, PA 19406-0939 (US)
Priority Data:
60/695,256 30.06.2005 US
Abstract: front page image
(EN)The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula I: Formula (I) where R1 , R2, R3, U and V are defined below and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKK&bgr;) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
(FR)L'invention concerne de nouveaux dérivés d'indole carboxamide. Plus particulièrement, l'invention concerne des composés de formule (I) dans laquelle R1, R2, R3, U et V sont définis ci-après et leurs sels pharmaceutiquement acceptables. Les composés de l'invention sont des inhibiteurs d'IKK2 et peuvent être utiles dans le traitement de troubles associés à une activité IKK2 appropriée (également connue comme IKK$g(b)), telle que la polyarthrite rhumatoïde, l'asthme et la MPOC (maladie pulmonaire obstructive chronique). En conséquence, l'invention concerne également des compositions pharmaceutiques renfermant un composant de l'invention. L'invention concerne également des méthodes d'inhibition de l'activité IKK2 et de traitement de troubles associés utilisant un composé de l'invention ou une composition pharmaceutique renfermant un composé de l'invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)